抄録
We have a little bit different choices in antifungal agents from the United States or other countries. The first edition of Japanaese practical guideline for fungal infectious diseases was published in 2003, when micafungin has been released. Amphotericin B, flucytosine, intravenous and oral fluconazole, itraconazole capsule, miconazole were antifungals that have been available before micafungin release. Since then, voriconazole, intravenous itraconazole and liposomal amphotericin B become available. Primary choice of antifungal in some situations such as invasive aspergillosis or prophylaxis changed accordingly. Another aspect of our guideline is a flowchart that connected diagnosis to antifungal choices. These charts were proposed according to each field of medical specialty. Since a guideline in Japan is not only for infectious diseases specialist but for all doctors including surgeons who might treat patients.
